Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives
Pharmaceutics · 24.01.2024 · 16 (2) · 161
DOI: 10.3390/pharmaceutics16020161 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 24.01.2024. Verfasst von Siyuan Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510275, China. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
With the development of nanotechnology and confronting the problems of traditional pharmaceutical formulations in treating lung diseases, inhalable nano-formulations have attracted interest. Inhalable nano-formulations for treating lung diseases allow for precise pulmonary drug delivery, overcoming physiological barriers, improving aerosol lung deposition rates, and increasing drug bioavailability. They are expected to solve the difficulties faced in treating lung diseases. However, limited success has been recorded in the industrialization translation of inhalable nano-formulations. Only one relevant product has been approved by the FDA to date, suggesting that there are still many issues to be resolved in the clinical application of inhalable nano-formulations. These systems are characterized by a dependence on inhalation devices, while the adaptability of device formulation is still inconclusive, which is the most important issue impeding translational research. In this review, we categorized various inhalable nano-formulations, summarized the advantages of inhalable nano-formulations over conventional inhalation formulations, and listed the inhalable nano-formulations undergoing clinical studies. We focused on the influence of inhalation devices on nano-formulations and analyzed their adaptability. After extensive analysis of the drug delivery mechanisms, technical processes, and limitations of different inhalation devices, we concluded that vibrating mesh nebulizers might be most suitable for delivering inhalable nano-formulations, and related examples were introduced to validate our view. Finally, we presented the challenges and outlook for future development. We anticipate providing an informative reference for the field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510275, China.
- College of Pharmacy, Jinan University, Guangzhou 510632, China.
ORCID-Profile: Zhengwei Huang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Peng, S., Wang, W., Zhang, R., Wu, C., Pan, X., & Huang, Z. (2024). Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives. Pharmaceutics, 16(2), 161. https://doi.org/10.3390/pharmaceutics16020161
Vancouver
Peng S, Wang W, Zhang R, Wu C, Pan X, Huang Z. Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives. Pharmaceutics. 2024;16(2):161. doi:10.3390/pharmaceutics16020161
BibTeX
@article{Peng2024,
author = {Peng, Siyuan and Wang, Wenhao and Zhang, Rui and Wu, Chuanbin and Pan, Xin and Huang, Zhengwei},
title = {Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {2},
pages = {161},
doi = {10.3390/pharmaceutics16020161}
}
EUVIMED